SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bhag Karamchandani who wrote (4264)5/7/1998 1:19:00 PM
From: Izzy  Read Replies (1) of 6136
 
Query for Bhag: Why would the "insiders" want to buy more shares? You mention in your last post that the lack of purchases by insiders "is probably the one of the most negative indicators hurting AGPH price." See Steve's post #3894 regarding insider trades (there may have been a subsequent post, just can't find it). These people are still holding a substantial number of shares (purchased/optioned at a very low price). I don't understand why they would want to buy more shares now and why you consider this to be such a major issue in the stock's current price. These people have been waiting for years to make their money and, for the past year, they finally have been rewarded financially for their work/efforts. Kudos to them. We should have been so lucky.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News